Compositions relating to novel compounds and targets thereof
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
1. A composition comprising the following formula:
wherein R1 is selected from the group consisting of H, alkyl, or substituted alkyl;
wherein R2 is selected from the group consisting of hydrogen, a hydroxy, an alkoxy, a halo, an amino, an alkyl group having 1–8 carbons and 1–20 hydrogens, a substituted amino, an acetylamino, a hydroxyamino, an aliphatic group having 1–8 carbons and 1–20 hydrogens, a cycloaliphatic group consisting of <10 carbons, a substituted cycloaliphatic group, an aryl, a heterocyclic; wherein R3 is selected from the group consisting of H, alkyl, or substituted alkyl, and wherein at most one substituent is a hydroxyl subgroup; wherein
R4 is selected from the group consisting of
wherein n=0–5; and wherein R 1 , R 2 , R 3 , and R 4 include both R or S enantiomeric forms and racemic mixtures.
2. The composition of claim 1 , wherein R1 is H.
3. The composition of claim 1 , wherein R4 is
4. The composition of claim 1 , wherein R4 is
5. The composition of claim 1 , wherein R4 is
6. The composition of claim 1 , wherein R4 is
7. The composition of claim 1 , wherein R4 is
8. The composition of claim 1 , wherein R4 is
9. The composition of claim 1 , wherein R4 is
10. The composition of claim 1 , wherein R4 is